Table 5. . Overall and progression-free survival (all patients).
Cohort A (metformin) | Cohort B (no metformin) |
---|---|
Overall survival | |
42.8% patients alive at 1 year | 32.7% patients alive at 1 year |
28.5% patients alive at 2 years | 26.2% patients alive at 2 years |
Progression-free survival | |
15.5% patients free from progression at 1 year -10.3% patients free from progression at 2 years |
16.5% patients free from progression at 1 year 5.5% patients free from progression at 2 years |